Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

DRDB vs GS vs MS vs JPM vs BAC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DRDB
Roman DBDR Acquisition Corp. II

Financial - Conglomerates

Financial ServicesNASDAQ • US
Market Cap$291M
5Y Perf.+5.7%
GS
The Goldman Sachs Group, Inc.

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$287.62B
5Y Perf.+48.8%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$302.59B
5Y Perf.+42.9%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$825.89B
5Y Perf.+15.7%
BAC
Bank of America Corporation

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$401.47B
5Y Perf.+14.4%

DRDB vs GS vs MS vs JPM vs BAC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DRDB logoDRDB
GS logoGS
MS logoMS
JPM logoJPM
BAC logoBAC
IndustryFinancial - ConglomeratesFinancial - Capital MarketsFinancial - Capital MarketsBanks - DiversifiedBanks - Diversified
Market Cap$291M$287.62B$302.59B$825.89B$401.47B
Revenue (TTM)$0.00$126.85B$103.14B$270.79B$188.75B
Net Income (TTM)$223K$16.67B$16.18B$58.03B$30.63B
Gross Margin41.1%55.6%58.6%55.4%
Operating Margin14.5%17.1%27.7%18.5%
Forward P/E1297.5x15.6x16.0x13.8x11.9x
Total Debt$0.00$616.93B$360.49B$751.15B$365.90B
Cash & Equiv.$1M$182.09B$75.74B$469.32B$231.84B

DRDB vs GS vs MS vs JPM vs BACLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DRDB
GS
MS
JPM
BAC
StockFeb 25May 26Return
Roman DBDR Acquisit… (DRDB)100105.7+5.7%
The Goldman Sachs G… (GS)100148.8+48.8%
Morgan Stanley (MS)100142.9+42.9%
JPMorgan Chase & Co. (JPM)100115.7+15.7%
Bank of America Cor… (BAC)100114.4+14.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: DRDB vs GS vs MS vs JPM vs BAC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GS leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Bank of America Corporation is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. DRDB also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
DRDB
Roman DBDR Acquisition Corp. II
The Banking Pick

DRDB ranks third and is worth considering specifically for sleep-well-at-night and defensive.

  • Lower volatility, beta 0.01, current ratio 4.63x
  • Beta 0.01, current ratio 4.63x
  • Beta 0.01 vs GS's 1.47
Best for: sleep-well-at-night and defensive
GS
The Goldman Sachs Group, Inc.
The Banking Pick

GS carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 17.0%, EPS growth 77.3%
  • 17.0% NII/revenue growth vs BAC's -1.9%
  • Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner)
  • +70.6% vs DRDB's +3.2%
Best for: growth exposure
MS
Morgan Stanley
The Banking Pick

MS is the clearest fit if your priority is long-term compounding.

  • 7.3% 10Y total return vs GS's 5.3%
Best for: long-term compounding
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is bank quality.

  • NIM 2.3% vs DRDB's 0.2%
Best for: bank quality
BAC
Bank of America Corporation
The Banking Pick

BAC is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.

  • Dividend streak 6 yrs, beta 1.00, yield 2.4%
  • PEG 0.77 vs MS's 1.80
  • Lower P/E (11.9x vs 13.8x), PEG 0.77 vs 1.06
  • 2.4% yield, 6-year raise streak, vs JPM's 1.7%, (1 stock pays no dividend)
Best for: income & stability and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthGS logoGS17.0% NII/revenue growth vs BAC's -1.9%
ValueBAC logoBACLower P/E (11.9x vs 13.8x), PEG 0.77 vs 1.06
Quality / MarginsGS logoGSEfficiency ratio 0.3% vs MS's 0.4% (lower = leaner)
Stability / SafetyDRDB logoDRDBBeta 0.01 vs GS's 1.47
DividendsBAC logoBAC2.4% yield, 6-year raise streak, vs JPM's 1.7%, (1 stock pays no dividend)
Momentum (1Y)GS logoGS+70.6% vs DRDB's +3.2%
Efficiency (ROA)GS logoGSEfficiency ratio 0.3% vs MS's 0.4%

DRDB vs GS vs MS vs JPM vs BAC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DRDBRoman DBDR Acquisition Corp. II

Segment breakdown not available.

GSThe Goldman Sachs Group, Inc.
FY 2024
Global Markets
65.3%$34.9B
Investment Management
30.2%$16.1B
Platform Solutions
4.5%$2.4B
MSMorgan Stanley
FY 2024
Wealth Management Segment
45.6%$28.4B
Institutional Securities Segment
45.0%$28.1B
Investment Management Segment
9.4%$5.9B
JPMJPMorgan Chase & Co.
FY 2024
Consumer & Community Banking
40.3%$71.5B
Commercial And Investment Bank
39.5%$70.1B
Asset and Wealth Management Segment
12.2%$21.6B
Segment Reporting, Reconciling Item, Corporate Nonsegment
9.8%$17.4B
Segment Reconciling Items
-1.7%$-3,037,000,000
BACBank of America Corporation
FY 2024
Loans and Leases
32.2%$62.0B
other interest income
14.7%$28.3B
Debt securities
13.5%$26.0B
Federal funds sold and securities borrowed or purchased under agreements to resell
10.3%$19.9B
Investment And Brokerage Services
9.2%$17.8B
Market making and similar activities
6.7%$13.0B
Trading account assets
5.4%$10.4B
Other (4)
7.8%$15.1B

DRDB vs GS vs MS vs JPM vs BAC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGMS

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 3 of 5 comparable metrics.

JPM and DRDB operate at a comparable scale, with $270.8B and $0 in trailing revenue. JPM is the more profitable business, keeping 21.6% of every revenue dollar as net income compared to GS's 11.3%.

MetricDRDB logoDRDBRoman DBDR Acquis…GS logoGSThe Goldman Sachs…MS logoMSMorgan StanleyJPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…
RevenueTrailing 12 months$0$126.9B$103.1B$270.8B$188.8B
EBITDAEarnings before interest/tax$23.4B$26.3B$81.3B$36.6B
Net IncomeAfter-tax profit$16.7B$16.2B$58.0B$30.6B
Free Cash FlowCash after capex$15.8B-$6.7B-$119.7B$12.6B
Gross MarginGross profit ÷ Revenue+41.1%+55.6%+58.6%+55.4%
Operating MarginEBIT ÷ Revenue+14.5%+17.1%+27.7%+18.5%
Net MarginNet income ÷ Revenue+11.3%+13.0%+21.6%+16.2%
FCF MarginFCF ÷ Revenue-12.1%-2.0%-15.5%+6.7%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+45.8%+48.9%+16.0%+18.3%
JPM leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

BAC leads this category, winning 5 of 6 comparable metrics.

At 13.8x trailing earnings, BAC trades at a 99% valuation discount to DRDB's 1297.5x P/E. Adjusting for growth (PEG ratio), BAC offers better value at 0.90x vs MS's 2.69x — a lower PEG means you pay less per unit of expected earnings growth.

MetricDRDB logoDRDBRoman DBDR Acquis…GS logoGSThe Goldman Sachs…MS logoMSMorgan StanleyJPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…
Market CapShares × price$291M$287.6B$302.6B$825.9B$401.5B
Enterprise ValueMkt cap + debt − cash$290M$722.5B$587.3B$1.11T$535.5B
Trailing P/EPrice ÷ TTM EPS1297.53x22.84x23.92x15.51x13.81x
Forward P/EPrice ÷ next-FY EPS est.15.64x16.01x13.79x11.86x
PEG RatioP/E ÷ EPS growth rate1.63x2.69x1.19x0.90x
EV / EBITDAEnterprise value multiple1295.57x34.75x25.81x13.34x14.63x
Price / SalesMarket cap ÷ Revenue2.27x2.93x3.05x2.13x
Price / BookPrice ÷ Book value/share1.44x2.53x2.91x2.56x1.31x
Price / FCFMarket cap ÷ FCF31.83x
BAC leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

JPM leads this category, winning 5 of 9 comparable metrics.

JPM delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $0 for DRDB. BAC carries lower financial leverage with a 1.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs DRDB's 3/9, reflecting strong financial health.

MetricDRDB logoDRDBRoman DBDR Acquis…GS logoGSThe Goldman Sachs…MS logoMSMorgan StanleyJPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…
ROE (TTM)Return on equity+0.1%+12.6%+14.6%+16.1%+10.1%
ROA (TTM)Return on assets+0.1%+0.9%+1.2%+1.3%+0.9%
ROICReturn on invested capital+1.9%+2.9%+5.4%+3.2%
ROCEReturn on capital employed-0.1%+3.6%+3.8%+8.2%+4.2%
Piotroski ScoreFundamental quality 0–934557
Debt / EquityFinancial leverage5.06x3.42x2.18x1.21x
Net DebtTotal debt minus cash-$1M$434.8B$284.7B$281.8B$134.1B
Cash & Equiv.Liquid assets$1M$182.1B$75.7B$469.3B$231.8B
Total DebtShort + long-term debt$0$616.9B$360.5B$751.1B$365.9B
Interest CoverageEBIT ÷ Interest expense0.31x0.44x0.74x0.44x
JPM leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in GS five years ago would be worth $26,440 today (with dividends reinvested), compared to $10,605 for DRDB. Over the past 12 months, GS leads with a +70.6% total return vs DRDB's +3.2%. The 3-year compound annual growth rate (CAGR) favors GS at 43.5% vs DRDB's 2.0% — a key indicator of consistent wealth creation.

MetricDRDB logoDRDBRoman DBDR Acquis…GS logoGSThe Goldman Sachs…MS logoMSMorgan StanleyJPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…
YTD ReturnYear-to-date+0.8%+1.8%+5.7%-5.0%-5.2%
1-Year ReturnPast 12 months+3.2%+70.6%+63.0%+25.2%+31.6%
3-Year ReturnCumulative with dividends+6.1%+195.2%+138.4%+134.6%+101.6%
5-Year ReturnCumulative with dividends+6.1%+164.4%+136.2%+104.3%+36.3%
10-Year ReturnCumulative with dividends+6.1%+534.3%+732.3%+461.3%+330.2%
CAGR (3Y)Annualised 3-year return+2.0%+43.5%+33.6%+32.9%+26.3%
GS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

DRDB leads this category, winning 2 of 2 comparable metrics.

DRDB is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than GS's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DRDB currently trades 99.6% from its 52-week high vs JPM's 90.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDRDB logoDRDBRoman DBDR Acquis…GS logoGSThe Goldman Sachs…MS logoMSMorgan StanleyJPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…
Beta (5Y)Sensitivity to S&P 5000.01x1.47x1.37x1.00x1.00x
52-Week HighHighest price in past year$10.55$984.70$194.83$337.25$57.55
52-Week LowLowest price in past year$10.16$547.74$118.20$248.83$40.86
% of 52W HighCurrent price vs 52-week peak+99.6%+94.0%+97.6%+90.8%+91.7%
RSI (14)Momentum oscillator 0–10059.359.566.059.459.8
Avg Volume (50D)Average daily shares traded288K2.0M5.4M8.3M36.0M
DRDB leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.

Analyst consensus: GS as "Hold", MS as "Buy", JPM as "Buy", BAC as "Buy". Consensus price targets imply 15.9% upside for BAC (target: $61) vs 7.6% for GS (target: $996). For income investors, BAC offers the higher dividend yield at 2.40% vs GS's 1.46%.

MetricDRDB logoDRDBRoman DBDR Acquis…GS logoGSThe Goldman Sachs…MS logoMSMorgan StanleyJPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$995.89$205.75$338.78$61.13
# AnalystsCovering analysts55526154
Dividend YieldAnnual dividend ÷ price+1.5%+2.0%+1.7%+2.4%
Dividend StreakConsecutive years of raises1211146
Dividend / ShareAnnual DPS$13.48$3.81$5.13$1.27
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.5%+1.4%+3.5%+5.3%
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BAC leads in 1 (Valuation Metrics). 1 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...

DRDB vs GS vs MS vs JPM vs BAC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is DRDB or GS or MS or JPM or BAC a better buy right now?

For growth investors, The Goldman Sachs Group, Inc.

(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus -1. 9% for Bank of America Corporation (BAC). Bank of America Corporation (BAC) offers the better valuation at 13. 8x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DRDB or GS or MS or JPM or BAC?

On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 13.

8x versus Roman DBDR Acquisition Corp. II at 1297. 5x. On forward P/E, Bank of America Corporation is actually cheaper at 11. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank of America Corporation wins at 0. 77x versus Morgan Stanley's 1. 80x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — DRDB or GS or MS or JPM or BAC?

Over the past 5 years, The Goldman Sachs Group, Inc.

(GS) delivered a total return of +164. 4%, compared to +6. 1% for Roman DBDR Acquisition Corp. II (DRDB). Over 10 years, the gap is even starker: MS returned +732. 3% versus DRDB's +6. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DRDB or GS or MS or JPM or BAC?

By beta (market sensitivity over 5 years), Roman DBDR Acquisition Corp.

II (DRDB) is the lower-risk stock at 0. 01β versus The Goldman Sachs Group, Inc. 's 1. 47β — meaning GS is approximately 14442% more volatile than DRDB relative to the S&P 500. On balance sheet safety, Bank of America Corporation (BAC) carries a lower debt/equity ratio of 121% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — DRDB or GS or MS or JPM or BAC?

By revenue growth (latest reported year), The Goldman Sachs Group, Inc.

(GS) is pulling ahead at 17. 0% versus -1. 9% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to 18. 6% for Bank of America Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DRDB or GS or MS or JPM or BAC?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 21. 6% net margin versus 0. 0% for Roman DBDR Acquisition Corp. II — meaning it keeps 21. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 27. 7% versus 0. 0% for DRDB. At the gross margin level — before operating expenses — JPM leads at 58. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DRDB or GS or MS or JPM or BAC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Bank of America Corporation (BAC) is the more undervalued stock at a PEG of 0. 77x versus Morgan Stanley's 1. 80x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 11. 9x forward P/E versus 16. 0x for Morgan Stanley — 4. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAC: 15. 9% to $61. 13.

08

Which pays a better dividend — DRDB or GS or MS or JPM or BAC?

In this comparison, BAC (2.

4% yield), MS (2. 0% yield), JPM (1. 7% yield), GS (1. 5% yield) pay a dividend. DRDB does not pay a meaningful dividend and should not be held primarily for income.

09

Is DRDB or GS or MS or JPM or BAC better for a retirement portfolio?

For long-horizon retirement investors, Roman DBDR Acquisition Corp.

II (DRDB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01)). Both have compounded well over 10 years (DRDB: +6. 1%, GS: +534. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DRDB and GS and MS and JPM and BAC?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DRDB is a small-cap quality compounder stock; GS is a large-cap high-growth stock; MS is a large-cap high-growth stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock. GS, MS, JPM, BAC pay a dividend while DRDB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

DRDB

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
Run This Screen
Stocks Like

GS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 6%
Run This Screen
Stocks Like

MS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 7%
Run This Screen
Stocks Like

JPM

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 12%
Run This Screen
Stocks Like

BAC

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 9%
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DRDB and GS and MS and JPM and BAC on the metrics below

P/E Ratio<
x
(DRDB: 1297.5x · GS: 22.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.